Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ultraviolet AII (UVA-II) radiation is a sub-band within the ultraviolet (UV) spectrum, with wavelengths ranging from approximately 320 to 340 nanometers. It penetrates deeply into the skin, contributing to photoaging and indirectly damaging DNA through the generation of reactive oxygen species. UVA-II exposure is associated with an increased risk of skin cancer and immunosuppression.
Indirect DNA damage via reactive oxygen species (ROS)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ultraviolet AII Radiation (None).